TANG CAPITAL MANAGEMENT LLC Portfolio
Auto-discovered 13F filer (Top-2000 by latest reported value).
SEC 13F CIK: 0001232621
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q4 2025 · 75 positions · Total reported value $2.02B · Top-10 concentration 52.9% · Updated 2026-10-18
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
Turnover: 15.2% · 5 new · 1 cut · 1 exited
Active Share (vs S&P 500): 99.9% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking
Est. Qtr Return (Q2 2026 → Q3 2026): -8.5% · vs SPY -10.6% · Prev Value $2.20B — last quarter positions weighted by this quarter price moves · ranking
Est. QTD Return (Q3 2026 → newest close): -3.0% · vs SPY -5.2% · Latest Value $2.17B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking
In its Q4 2025 13F filing, TANG CAPITAL MANAGEMENT LLC disclosed 75 equity positions with a combined reported value of $2.02B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 52.9% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt.
The largest disclosed positions as of Q4 2025 were AUPH ($180.71M), LKFT ($128.22M), PTCT ($113.94M). By sector, the heaviest allocations are Health Care 81.4%, Technology 1.9%. Versus the prior quarter, allocation shifted toward Other (+2.5pp), Health Care (+0.6pp) and away from Consumer Discretionary (-2.4pp).
Versus the prior quarter, TANG CAPITAL MANAGEMENT LLC opened 5 new positions, trimmed 1 and fully exited 1, a turnover rate of 15.2% of positions. The portfolio's overlap with the prior quarter was 34% of names.
The largest new positions opened in Q4 2025 were RNAM ($64.92M), CAPR ($49.06M), SPY ($20.46M).
Of the 1 positions fully exited versus the prior quarter, the largest were MRUS ($56.49M), RLAY ($42.12M), VERA ($39.23M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q4 2025)
Fully Exited (vs previous quarter)
- MRUS MERUS N V · prev qtr: $56.49M
- RLAY RELAY THERAPEUTICS INC · prev qtr: $42.12M
- VERA VERA THERAPEUTICS INC · prev qtr: $39.23M · history
- NKE NIKE INC · prev qtr: $36.22M
- IONS IONIS PHARMACEUTICALS INC · prev qtr: $35.98M
- CTMX CYTOMX THERAPEUTICS INC. · prev qtr: $35.30M
- AVDL AVADEL PHARMACEUTICALS · prev qtr: $32.03M
- LEGN LEGEND BIOTECH CORP · prev qtr: $27.07M · history
Insider Transactions (Form 4)
Latest TANG CAPITAL MANAGEMENT LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
| Transaction date | Activity | Security | Shares | Price | Filing |
|---|---|---|---|---|---|
| 2026-11-10 | Buy | Boundless Bio, Inc. | 249 | $2.40 | SEC filing |
| 2026-11-06 | Buy | Boundless Bio, Inc. | 1,700 | $2.40 | SEC filing |
| 2026-11-05 | Buy | Boundless Bio, Inc. | 8,390 | $2.40 | SEC filing |
| 2026-11-04 | Buy | Boundless Bio, Inc. | 517 | $2.40 | SEC filing |
| 2026-11-03 | Buy | Boundless Bio, Inc. | 2,255 | $2.40 | SEC filing |
| 2026-10-27 | Buy | Boundless Bio, Inc. | 10,707 | $2.40 | SEC filing |
| 2026-10-26 | Buy | Boundless Bio, Inc. | 9,606 | $2.38 | SEC filing |
| 2026-10-23 | Buy | Boundless Bio, Inc. | 6,234 | $2.38 | SEC filing |
Fund Profile
Tang Capital Management is an SEC-registered 13F filer. As of Q3 2026 it reported 45 US equity positions with a combined value of $2.17B. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).
Portfolio Structure
- 45 positions · $2.17B reported value (Q3 2026)
- Top 10 holdings = 64.3% of reported value
- Largest position: AUPH (AURINIA PHARMACEUTICALS INC) at 9.7%
- Average position size: $48.31M
Sector Tilt
- Health Care 89.7%
- Information Technology 1.5%
- (classified holdings cover 91% of value)
Quarterly Activity
- Q3 2026: 5 new, 12 added, 1 reduced, 1 exited
- 27 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
11.33M | $180.71M | 8.93% | Hold | |
| 2 |
|
3.92M | $128.22M | 6.33% | Reduce | |
| 3 |
|
1.50M | $113.94M | 5.63% | Hold | |
| 4 |
|
1.05M | $104.73M | 5.17% | Reduce | |
| 5 |
|
1.24M | $97.63M | 4.82% | Hold | |
| 6 |
|
1.19M | $97.32M | 4.81% | Reduce | |
| 7 |
|
2.26M | $93.22M | 4.61% | Reduce | |
| 8 |
|
2.63M | $91.24M | 4.51% | Add | |
| 9 |
|
16.79M | $90.17M | 4.45% | Hold | |
| 10 |
|
4.57M | $73.86M | 3.65% | Reduce | |
| 11 |
|
900.00K | $64.92M | 3.21% | New | |
| 12 |
|
1.33M | $64.58M | 3.19% | Hold | |
| 13 |
|
1.89M | $61.99M | 3.06% | Reduce | |
| 14 |
|
1.79M | $55.79M | 2.76% | Reduce | |
| 15 |
|
1.70M | $49.06M | 2.42% | New | |
| 16 |
|
470.00K | $44.74M | 2.21% | Add | |
| 17 |
|
481.44K | $38.00M | 1.88% | Add | |
| 18 |
|
80.00K | $36.27M | 1.79% | Hold | |
| 19 |
|
3.86M | $34.56M | 1.71% | Reduce | |
| 20 |
|
700.00K | $26.75M | 1.32% | Hold | |
| 21 |
|
2.81M | $25.41M | 1.25% | Reduce | |
| 22 |
|
127.79K | $23.83M | 1.18% | Reduce | |
| 23 |
|
5.62M | $23.48M | 1.16% | Reduce | |
| 24 |
|
30.00K | $20.46M | 1.01% | New | |
| 25 |
|
692.82K | $20.43M | 1.01% | Add | |
| 26 |
|
500.00K | $17.59M | 0.87% | Reduce | |
| 27 |
|
4.81M | $17.19M | 0.85% | Hold | |
| 28 |
|
500.00K | $15.87M | 0.78% | Hold | |
| 29 |
|
450.00K | $15.56M | 0.77% | Add | |
| 30 |
|
23.33K | $15.40M | 0.76% | Reduce | |
| 31 |
|
300.00K | $14.71M | 0.73% | Reduce | |
| 32 |
|
1.85M | $14.30M | 0.71% | Hold | |
| 33 |
|
865.17K | $13.84M | 0.68% | Reduce | |
| 34 |
|
275.00K | $12.69M | 0.63% | Reduce | |
| 35 |
|
264.69K | $10.91M | 0.54% | Hold | |
| 36 |
|
290.29K | $10.86M | 0.54% | Add | |
| 37 |
|
200.00K | $10.79M | 0.53% | New | |
| 38 |
|
60.00K | $10.44M | 0.52% | Reduce | |
| 39 |
|
872.40K | $10.35M | 0.51% | Add | |
| 40 |
|
600.00K | $10.20M | 0.50% | New | |
| 41 |
|
1.40M | $9.80M | 0.48% | Hold | |
| 42 |
|
556.36K | $8.56M | 0.42% | Reduce | |
| 43 |
|
1.25M | $8.28M | 0.41% | Reduce | |
| 44 |
|
1.07M | $8.26M | 0.41% | Add | |
| 45 |
|
350.00K | $8.20M | 0.41% | Reduce | |
| 46 |
|
6.25M | $8.12M | 0.40% | Add | |
| 47 |
|
300.00K | $8.01M | 0.40% | Reduce | |
| 48 |
|
2.13M | $7.69M | 0.38% | Hold | |
| 49 |
|
349.22K | $7.52M | 0.37% | Reduce | |
| 50 |
|
6.14M | $7.49M | 0.37% | Add | |
FAQ
What did TANG CAPITAL MANAGEMENT LLC buy in 2025-Q4?
In its 2025-Q4 13F filing, TANG CAPITAL MANAGEMENT LLC reported 75 equity positions worth $2.02B in aggregate; its largest disclosed positions were AUPH ($180.71M), LKFT ($128.22M), PTCT ($113.94M).
How large is TANG CAPITAL MANAGEMENT LLC's portfolio?
TANG CAPITAL MANAGEMENT LLC reported $2.02B of long equity holdings across 75 positions as of 2025-Q4. Top-10 holdings account for 52.9% of reported value.
What is TANG CAPITAL MANAGEMENT LLC's investment style?
HoldingsHub classifies the portfolio as Mid / Health Tilt, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.